“Edarbi® NRDL Launch Conference” was held in Beijing, Shanghai and Guangzhou on March 25 of 2023. More than 280 top domestic experts in the field of cardiovascular disease and management team from Hasten Biopharma attended the event, focusing on the review of the history for hypertension prevention and treatment in China during the past 30 years and discussion on a new chapter of blood pressure lowering and standardization.

(August 19, 2022) In order to further help improve the rate for awareness of hypertension management in the population, the "Easy“ to Meet the Standard - 2022 Cardiovascular Disease Blood Pressure Standard Achievement Program, initiated by the Suzhou Industrial Park Institute of Cardiovascular Health and supported by Hasten Biopharma. The kick-off meeting of the management project was successfully held in the afternoon of August 19, 2022 in Hefei, Anhui Province, China, in the session of the International Conference on Cardiovascular Diseases of Confucianism. The conference focused on optimal management of hypertension and its related hot issues.